Nanna Skeltved
Ph.d.-fellow
ORCID: 0000-0003-2300-2052
PhD student trying to cure cancer by targeting oncofetal chondroitin sulfate with a bispecific T-cell engaging antibody administered as mRNA.
ID: 284152912
Most downloads
-
39
downloads
Development of a bispecific immune engager using a recombinant malaria protein
Research output: Contribution to journal › Journal article › peer-review
Published